National Health Investors Inc. (NHI) Shares Down 2.5%
National Health Investors Inc. (NYSE:NHI)’s share price dropped 2.5% during mid-day trading on Friday . The company traded as low as $79.48 and last traded at $79.70, with a volume of 211,467 shares. The stock had previously closed at $81.78.
NHI has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $86.00 price target on the stock in a research report on Wednesday, July 27th. Cantor Fitzgerald initiated coverage on National Health Investors in a research report on Thursday, June 23rd. They set a “hold” rating and a $70.00 price target on the stock. Mizuho increased their price target on National Health Investors from $66.00 to $77.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Finally, JMP Securities reiterated a “hold” rating on shares of National Health Investors in a research report on Saturday, June 4th. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $72.50.
The stock has a market capitalization of $3.13 billion and a price-to-earnings ratio of 18.46. The company’s 50-day moving average price is $78.34 and its 200 day moving average price is $70.12.
National Health Investors (NYSE:NHI) last posted its earnings results on Friday, August 5th. The real estate investment trust reported $1.22 EPS for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.01. The firm had revenue of $61.20 million for the quarter, compared to analyst estimates of $58.08 million. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.17 EPS. Equities analysts expect that National Health Investors Inc. will post $4.87 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, November 10th. Investors of record on Friday, September 30th will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.50%. The ex-dividend date is Wednesday, September 28th.
In related news, Director Robert A. Mccabe, Jr. sold 1,250 shares of the business’s stock in a transaction dated Monday, June 13th. The stock was sold at an average price of $71.61, for a total value of $89,512.50. Following the transaction, the director now owns 9,736 shares in the company, valued at approximately $697,194.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kristin Sallee Gaines sold 4,044 shares of the business’s stock in a transaction dated Tuesday, June 28th. The shares were sold at an average price of $73.71, for a total value of $298,083.24. Following the completion of the transaction, the insider now owns 53,089 shares in the company, valued at approximately $3,913,190.19. The disclosure for this sale can be found here.
A hedge fund recently raised its stake in National Health Investors stock. Westfield Capital Management Co. LP increased its stake in shares of National Health Investors Inc. (NYSE:NHI) by 81.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 436,425 shares of the real estate investment trust’s stock after buying an additional 195,807 shares during the period. Westfield Capital Management Co. LP owned about 1.16% of National Health Investors worth $26,565,000 as of its most recent filing with the SEC.
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.